Physician profile
Fanny Elahi
NPI 1235424086
$16,254.82
in general payments reported to CMS, 2019-2025
7 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,587 · 2022: $9,130 · 2023: $1,400 · 2024: $3,010 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,704 · Travel and Lodging: $1,303 · Food and Beverage: $507 · Gift: $24.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,703.72 |
| Travel and Lodging | $1,302.88 |
| Food and Beverage | $507.49 |
| Gift | $24.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $7,716.51 | 2019-2022 | |
| Grifols, S.A. | $4,000.00 | 2022 | |
| Biogen, INC. | $1,919.73 | 2024-2025 | Leqembi |
| Genentech USA, INC. | $1,306.14 | 2023 | |
| Alexion Pharmaceuticals, INC. | $1,180.00 | 2024 | |
| Genentech, INC. | $94.33 | 2023 | |
| Hikma Pharmaceuticals USA | $38.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fanny Elahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.